Autor:	Caroline L. Behr, Karen E. Joynt Maddox, Ellen Meara, Arnold M. Epstein, E. John Orav, Michael L. Barnett
Rok vydání:	2022
Předmět:	Prescription Drugs Research Letter Antibodies Monoclonal Humans General Medicine Medicare Risk Assessment United States COVID-19 Drug Treatment
Zdroj:	JAMA
ISSN:	1538-3598
Popis:	This study assesses how a limited supply of monoclonal antibody therapy was allocated to patients at highest risk of severe disease among a population of fee-for-service Medicare beneficiaries with a new COVID-19 diagnosis or confirmed exposure between November 2020 and August 2021.
Databáze:	OpenAIRE
Externí odkaz:	https://explore.openaire.eu/search/publication?articleId=doi_dedup___::360b344c46aa6933cab255fe942f8d2f https://pubmed.ncbi.nlm.nih.gov/35119452 Zobrazit plný text záznamu